These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31393238)

  • 1. Current Psychopharmacology of Obsessive-Compulsive Spectrum Disorders.
    Del Casale A; Kotzalidis GD; Rapinesi C; Girardi P
    Curr Neuropharmacol; 2019; 17(8):668-671. PubMed ID: 31393238
    [No Abstract]   [Full Text] [Related]  

  • 2. EDITORIAL: Current Psychopharmacology of Obsessive-Compulsive Spectrum Disorders.
    Del Casale A; Kotzalidis GD; Rapinesi C; Girardi P
    Curr Neuropharmacol; 2019 Aug; 17(8):668-671. PubMed ID: 32194358
    [No Abstract]   [Full Text] [Related]  

  • 3. Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trial.
    Häge A; Banaschewski T; Buitelaar JK; Dijkhuizen RM; Franke B; Lythgoe DJ; Mechler K; Williams SC; Dittmann RW;
    Trials; 2016 Mar; 17(1):141. PubMed ID: 26983548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of psychopharmacology in obsessive compulsive disorders.
    Sarwer-Foner GJ
    Psychiatr J Univ Ott; 1987 Nov; 12(4):197-202. PubMed ID: 3326003
    [No Abstract]   [Full Text] [Related]  

  • 5. Contemporary approaches to pharmacotherapy in Tourette's syndrome and obsessive-compulsive disorder.
    Scahill L
    J Child Adolesc Psychiatr Nurs; 1996; 9(1):27-43. PubMed ID: 8696657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopharmacology of drugs effective in obsessive-compulsive disorder.
    Taniguchi G
    J Clin Psychopharmacol; 1988 Feb; 8(1):71. PubMed ID: 3351005
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
    Kamijima K; Aoki M
    Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inositol treatment of obsessive-compulsive disorder.
    Fux M; Levine J; Aviv A; Belmaker RH
    Am J Psychiatry; 1996 Sep; 153(9):1219-21. PubMed ID: 8780431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of anticonvulsants in the treatment of obsessive-compulsive and related disorders.
    Wang HR; Woo YS; Bahk WM
    Psychiatry Clin Neurosci; 2014 Oct; 68(10):723-32. PubMed ID: 24735021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open trial of fluoxetine in obsessive-compulsive disorder.
    Jenike MA; Buttolph L; Baer L; Ricciardi J; Holland A
    Am J Psychiatry; 1989 Jul; 146(7):909-11. PubMed ID: 2787123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology.
    Baldwin DS; Anderson IM; Nutt DJ; Allgulander C; Bandelow B; den Boer JA; Christmas DM; Davies S; Fineberg N; Lidbetter N; Malizia A; McCrone P; Nabarro D; O'Neill C; Scott J; van der Wee N; Wittchen HU
    J Psychopharmacol; 2014 May; 28(5):403-39. PubMed ID: 24713617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obsessive-compulsive disorder.
    Zetin M; Kramer MA
    Hosp Community Psychiatry; 1992 Jul; 43(7):689-99. PubMed ID: 1516899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What Future Role Might N-Acetyl-Cysteine Have in the Treatment of Obsessive Compulsive and Grooming Disorders?: A Systematic Review.
    Smith L; Tracy DK; Giaroli G
    J Clin Psychopharmacol; 2016 Feb; 36(1):57-62. PubMed ID: 26629962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of obsessive-compulsive personality disorder in antiobsessional pharmacological treatment.
    Cavedini P; Erzegovesi S; Ronchi P; Bellodi L
    Eur Neuropsychopharmacol; 1997 Feb; 7(1):45-9. PubMed ID: 9088884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New findings in obsessive-compulsive disorder.
    Kim SW; Dysken MW
    Minn Med; 1989 Feb; 72(2):91-3, 110. PubMed ID: 2651867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy for patients with obsessive-compulsive spectrum disorder--special reference to the pharmacotherapy and the trends in DSM-5].
    Matsunaga H
    Seishin Shinkeigaku Zasshi; 2011; 113(10):983-4. PubMed ID: 22292197
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluvoxamine treatment of obsessive-compulsive disorder.
    Perse TL; Greist JH; Jefferson JW; Rosenfeld R; Dar R
    Am J Psychiatry; 1987 Dec; 144(12):1543-8. PubMed ID: 3120604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is an obsessive-compulsive disorder in children an anxiety disorder?].
    Jalenques I; Coudert AJ
    Acta Psychiatr Belg; 1989; 89(5-6):325-37. PubMed ID: 2577944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical Review of the Use of Second-Generation Antipsychotics in Obsessive-Compulsive and Related Disorders.
    Kim D; Ryba NL; Kalabalik J; Westrich L
    Drugs R D; 2018 Sep; 18(3):167-189. PubMed ID: 30171515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of long-term fluoxetine treatment of obsessive-compulsive disorder.
    Frenkel A; Rosenthal J; Nezu A; Winston A
    Mt Sinai J Med; 1990 Nov; 57(6):348-52. PubMed ID: 2079952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.